Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.
Maurits Lugard, Dr. Dorothee Schramm, and Anna-Shari Melin from law firm Sidley & Austin explain how pharmaceutical companies with products on the EU market can address product shortages and supply chain issues in the current Covid-19 crisis.
The generics industry is a crucial partner in the fight against Covid-19 where cross-industry partnerships and alliances are creating a new normal, writes Tony Cordrey, VP Operations, Accord Healthcare EMENA.
Bryan Edwards distribution manager & responsible person at Almac Pharma Services details the financial and custom considerations for bringing an orphan drug to market.
Craig Stanford, head of Vendor Managed Services, Rubix, explains how vendor managed services make it easier for pharmaceutical businesses to purchase and restock consumables.
Maurits Lugard, partner at Sidley Austin’s Life Sciences practice, and Anna-Shari Melin, associate at Sidley Austin write about the measures being put into place to prevent and manage medicinal product shortages in the EU.
Suzanne Ward, senior director of medical strategy at Boston Scientific, examines supply chains in 2020 and why patients should be aware of what's really in the medicines they take.
